315 related articles for article (PubMed ID: 22406224)
1. Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis.
Martin P; Teodoro WR; Velosa AP; de Morais J; Carrasco S; Christmann RB; Goldenstein-Schainberg C; Parra ER; Katayama ML; Sotto MN; Capelozzi VL; Yoshinari NH
Autoimmun Rev; 2012 Sep; 11(11):827-35. PubMed ID: 22406224
[TBL] [Abstract][Full Text] [Related]
2. Unusual remodeling of the hyalinization band in vulval lichen sclerosus by type V collagen and ECM 1 protein.
Godoy CA; Teodoro WR; Velosa AP; Garippo AL; Eher EM; Parra ER; Sotto MN; Capelozzi VL
Clinics (Sao Paulo); 2015 May; 70(5):356-62. PubMed ID: 26039953
[TBL] [Abstract][Full Text] [Related]
3. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis.
Kissin EY; Merkel PA; Lafyatis R
Arthritis Rheum; 2006 Nov; 54(11):3655-60. PubMed ID: 17075814
[TBL] [Abstract][Full Text] [Related]
4. [Expression and distribution of type I, III and V collagens in skin lesions from patients with systemic sclerosis].
Liu T; Zhang J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):748-52. PubMed ID: 19024305
[TBL] [Abstract][Full Text] [Related]
5. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement.
Truchetet ME; Brembilla NC; Montanari E; Lonati P; Raschi E; Zeni S; Fontao L; Meroni PL; Chizzolini C
Arthritis Rheum; 2013 May; 65(5):1347-56. PubMed ID: 23335253
[TBL] [Abstract][Full Text] [Related]
7. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.
Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029
[TBL] [Abstract][Full Text] [Related]
8. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
[TBL] [Abstract][Full Text] [Related]
9. Scleroderma-like remodeling induced by type V collagen.
Bezerra MC; Teodoro WR; de Oliveira CC; Velosa AP; Ogido LT; Gauditano G; Parra ER; Capelozzi VL; Yoshinari NH
Arch Dermatol Res; 2006 Jul; 298(2):51-7. PubMed ID: 16710740
[TBL] [Abstract][Full Text] [Related]
10. Collagen V nasal tolerance in experimental model of systemic sclerosis.
Velosa AP; Teodoro WR; de Oliveira CC; Dos Santos Filho A; Moutinho RF; Santos AG; Vendramini MB; Bueno C; Parra ER; Capelozzi VL; Yoshinari NH
Arch Dermatol Res; 2007 Jul; 299(4):177-89. PubMed ID: 17297604
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosis.
Avouac J; Clemessy M; Distler JH; Gasc JM; Ruiz B; Vacher-Lavenu MC; Wipff J; Kahan A; Boileau C; Corvol P; Allanore Y
Rheumatology (Oxford); 2011 Aug; 50(8):1494-504. PubMed ID: 21454305
[TBL] [Abstract][Full Text] [Related]
12. Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis.
Parra ER; Teodoro WR; de Morais J; Katayama ML; de Souza R; Yoshinari NH; Capelozzi VL
Eur J Clin Invest; 2010 Feb; 40(2):110-20. PubMed ID: 19968698
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
[TBL] [Abstract][Full Text] [Related]
15. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
Postiglione L; Ladogana P; Montagnani S; di Spigna G; Castaldo C; Turano M; Bruno EM; Di Meglio F; Riccio A; Rossi G
J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
[TBL] [Abstract][Full Text] [Related]
16. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ
J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
[TBL] [Abstract][Full Text] [Related]
17. Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse.
Ong VH; Evans LA; Shiwen X; Fisher IB; Rajkumar V; Abraham DJ; Black CM; Denton CP
Arthritis Rheum; 2003 Jul; 48(7):1979-91. PubMed ID: 12847692
[TBL] [Abstract][Full Text] [Related]
18. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
[TBL] [Abstract][Full Text] [Related]
19. Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts.
Kajihara I; Jinnin M; Yamane K; Makino T; Honda N; Igata T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
Am J Pathol; 2012 Feb; 180(2):703-14. PubMed ID: 22142808
[TBL] [Abstract][Full Text] [Related]
20. Skin involvement in scleroderma--where histological and clinical scores meet.
Verrecchia F; Laboureau J; Verola O; Roos N; Porcher R; Bruneval P; Ertault M; Tiev K; Michel L; Mauviel A; Farge D
Rheumatology (Oxford); 2007 May; 46(5):833-41. PubMed ID: 17255134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
